Arca
Skip to content
Tools
Tools

Gem

Device, Vascular, For Promoting Embolization. 510(k) K213385, from Obsidio, Inc. (Columbia, SC). Product code KRD, class 2.

As of Nov 19, 2026, K213385 is an FDA 510(k) held by Obsidio, Inc., substantially equivalent on Jul 1, 2022 after 261 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 261 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

Obsidio GEM TM is indicated for use in the embolization of: • Hypervascular tumors, - Blood vessels to occlude blood flow for controlling bleeding/hemorrhaging in the peripheral vasculature.

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K213385, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Feb 20, 2024Z-1374-2024An investigation determined that delivery of the Obsidio embolic using the aliquot technique for lower gastrointestinal bleeding embolization poses a high risk of bowel ischemia. The most serious and the most common…Open

Other KRD clearances

The newest 510(k)s for the same product code; their median review was 70 days; see every KRD device

Record

Type
Traditional
Received
Oct 13, 2021
Review panel
Cardiovascular
Regulation
21 CFR 870.3300

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.